Annual/Quarterly Reports Summary
AbbVie is a global biopharmaceutical company that has achieved top-tier financial performance through outstanding execution. It has a comprehensive product portfolio with leadership positions across immunology, oncology, aesthetics, neuroscience and...
November 6, 2023 ABBV 0.44%
The company's financials have seen a decrease in revenue and an increase in operating expenses over the past three years. Net income margin was $61 million, higher than the industry...
November 6, 2023 CEG -0.74%
Berkshire Hathaway Inc.'s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 includes financial information such as the Consolidated Balance Sheets, Consolidated Statements of Earnings, and Consolidated...
November 6, 2023 BRK-B 0.33%
The third quarter of 2023 saw a 7% increase in revenue compared to the same period in 2022, driven by higher revenues in equity financing products. Operating expenses increased significantly,...
November 3, 2023 GS 0.16%
The Company has grown steadily over the past three years, driven by increases in rental and other lease income, management, development and other fees, and non-lease related revenue. Operating expenses...
November 3, 2023 AVB 0.37%
Organic total revenue increased for the third quarter and first three quarters, driven by strong growth in recurring revenue. Operating income and operating income as a percentage of revenue increased...
November 3, 2023 TRMB 1.11%
W. R. Berkley Corporation is an insurance holding company that has seen steady revenue growth over the past three years. Operating expenses have increased, but the company has implemented cost-cutting...
November 3, 2023 WRB 1.46%
Merck & Co. has seen strong revenue growth over the past three years, driven by higher sales in the oncology, vaccines, and virology franchises. Management has implemented initiatives to control...
November 3, 2023 MRK 2.49%